Latest Articles

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval - Voice of Alexandria

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval Voice of Alexandria

Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan

Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval Stock Titan

EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga

EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Benzinga

Diffuse Adenomyosis Coexisting with rASRM Stage IV Endometriosis in a | IJWH - Dove Medical Press

Diffuse Adenomyosis Coexisting with rASRM Stage IV Endometriosis in a | IJWH Dove Medical Press

'This was a monster': Families return to devastation after Washington fires - newscentermaine.com

'This was a monster': Families return to devastation after Washington fires newscentermaine.com

Mary Rivera, known for 'Spider-Man: No Way Home,' dies at 82 - newscentermaine.com

Mary Rivera, known for 'Spider-Man: No Way Home,' dies at 82 newscentermaine.com

Who Starts for LSU? FULL Fall Camp Breakdown - newscentermaine.com

Who Starts for LSU? FULL Fall Camp Breakdown newscentermaine.com

RUMORS: What is the IDEAL Roster for the Cleveland Cavaliers?! | Who is UNTOUCHABLE! - newscentermaine.com

RUMORS: What is the IDEAL Roster for the Cleveland Cavaliers?! | Who is UNTOUCHABLE! newscentermaine.com

Letter regarding decreased anti-Müllerian hormone in women with superficial peritoneal endometriosis by Griffiths et al.

When It's Not Just "That Time of the Month": Identifying Thoracic Endometriosis in the Context of Recurrent Pleural Effusion.

Recurrent hemorrhagic pleural effusion presents as a challenge for both the clinician and the patient, with common causes being tuberculosis, malignancy, and collagen vascular diseases. Among uncommon causes of recurrent …